PG Richardson
Impact in
- Transplantation top 2%
- Renal Transplantation Outcomes and Treatments
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
Papers in
- Hematology 37
- Multiple Myeloma Research and Treatments 33
-
- Protein Degradation and Inhibitors 13
- Cancer therapeutics and mechanisms 4
- Co-authors
- Frank M. Torti (1 shared paper)B L Lum (1 shared paper)Gerald J. Berry (1 shared paper)A. J. Patek (1 shared paper)Edwin L. Alderman (1 shared paper)Francisco J. Plaza Martín (1 shared paper)Margaret E. Billingham (1 shared paper)Richard E. Clark (2 shared papers)
- Journals
- Journal of Clinical Oncology (18 papers)HemaSphere (6 papers)Blood (5 papers)Haematologica (3 papers)Annals of Oncology (1 paper)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
PG Richardson
50 papers receiving 800 citations
Peers
Comparison fields: 5 of 83
- Transplantation 117
- Hematology 328
- Nephrology 86
- Immunology 196
- Oncology 206
Countries citing papers authored by PG Richardson
This map shows the geographic impact of PG Richardson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by PG Richardson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites PG Richardson more than expected).
Fields of papers citing papers by PG Richardson
This network shows the impact of papers produced by PG Richardson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by PG Richardson. The network helps show where PG Richardson may publish in the future.
Co-authors
The 25 scholars most cited alongside PG Richardson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 294 | |
| 2 | 1998 | 218 | |
| 3 | 2014 | 36 | |
| 4 | 2012 | 29 | |
| 5 | 1991 | 28 | |
| 6 | A phase 1 study of oral CC5013, an immunomodulatory thalidomide (Thal) derivative, in patients with relapsed and refractory multiple myeloma (MM). | 2001 | 24 |
| 7 | 1987 | 16 | |
| 8 | 2005 | 15 | |
| 9 | 1986 | 13 | |
| 10 | 2011 | 12 | |
| 11 | 1992 | 11 | |
| 12 | 1991 | 10 | |
| 13 | 2005 | 10 | |
| 14 | 2011 | 9 | |
| 15 | 2011 | 9 | |
| 16 | 2005 | 9 | |
| 17 | 2008 | 9 | |
| 18 | 2004 | 9 | |
| 19 | 2005 | 7 | |
| 20 | 2010 | 7 |
About PG Richardson
PG Richardson is a scholar working on Hematology, Molecular Biology, Genetics, Oncology and Pathology and Forensic Medicine, having authored 51 papers that have together received 849 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (33 papers), Protein Degradation and Inhibitors (13 papers), Chronic Lymphocytic Leukemia Research (11 papers), Cancer Treatment and Pharmacology (5 papers), HIV/AIDS drug development and treatment (4 papers), Cancer therapeutics and mechanisms (4 papers), Peptidase Inhibition and Analysis (4 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Transplantation (117 citations), Hematology (328 citations), Nephrology (86 citations), Immunology (196 citations) and Oncology (206 citations). PG Richardson has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Frank M. Torti, B L Lum, Gerald J. Berry, A. J. Patek, Edwin L. Alderman, Francisco J. Plaza Martín, Margaret E. Billingham, Richard E. Clark, Tiziano Barbui and Karim Kentouche. Their work appears in journals such as Journal of Clinical Oncology, HemaSphere, Blood, Haematologica and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.